Qualification of Drivers; Exemption Applications; Diabetes Mellitus, 12890-12891 [2017-04384]

Download as PDF sradovich on DSK3GMQ082PROD with NOTICES 12890 Federal Register / Vol. 82, No. 43 / Tuesday, March 7, 2017 / Notices As of December 20, 2016, and in accordance with 49 U.S.C. 31136(e) and 31315, the following 17 individuals have satisfied the renewal conditions for obtaining an exemption from the rule prohibiting drivers with ITDM from driving CMVs in interstate commerce (77 FR 63411; 77 FR 64181; 77 FR 75492; 77 FR 75493): James D. Astle (OH) Robert E. Carroll (FL) Thomas L. Gilmore (IA) Kenneth M. Hansen (IA) David J. Heppelmann (MN) Dennis R. Johnson (TN) Ronald D. Johnston (VA) Steven M. Knezevich (MI) Phil J. Kunkel (IN) Carl E. McCartney (PA) Fred Nelson, Jr. (PA) Ricky L. Osterback (WA) Joseph M. Polkowski, Sr. (PA) Dan R. Stark (MN) Chad E. Vanscoy (OH) Mark A. Welch, Jr. (PA) Bailey G. Zickefoose, Jr. (WV) The drivers were included in docket No: FMCSA–2012–0283. Their exemptions are effective as of December 20, 2016, and will expire on December 20, 2018. As of December 29, 2016, and in accordance with 49 U.S.C. 31136(e) and 31315, the following 45 individuals have satisfied the renewal conditions for obtaining an exemption from the rule prohibiting drivers with ITDM from driving CMVs in interstate commerce (79 FR 70920; 80 FR 5613): Andrew P. Bivens (TN) Everett D. Blevins (KY) Kirk J. Brummeler (GA) Travis M. Bryan (MA) Robert A. Chess (PA) John W. Condy (NY) Kevin V. Cook (MO) Guido Criscuolo, Jr. (CT) Zachary L. Diehl (IL) Andrea I. Dirksen (IA) David D. Dowdy (IL) Clarice L. Dunklin (LA) Ricky L. Exler (FL) Paul B. Fuerstenberg (WI) Nathan M. Gallant (TX) Louis A. Goodenough (IN) Tyler L. Gravatt (ID) Gary W. Honaker (VA) David G. Horne (VA) Glenn A. Keifer (SD) Rex L. Kreutzer (NE) Larry D. Lloyd (OR) Dennis D. Markowski (WA) William F. Melchert-Dinkel (MN) Brit K. Miller (SD) Charles B. Petersen (ID) Anthony J. Politan (IN) Emil T. Ricci (PA) Arturo Robles (WY) VerDate Sep<11>2014 16:01 Mar 06, 2017 Jkt 241001 Robert F. Rothbauer (WI) Michael A. Runyan, Jr. (NC) John D. Sheets (NH) Kyle L. Shuman (NY) Jerry W. Smay (CA) Gregory A. Smith (GA) William S. Spaeth (WI) Eloy G. Tijerina (TX) Santos R. Torres (TX) Leroy A. Traudt (NE) Arthur R. Vance (VA) Gerald S. Volpone, Jr. (MA) Galen R. Watts (TX) William R. Welch, Jr. (VA) John E. Wildenmann (KY) Edward D. Wright (IN) The drivers were included in docket No: FMCSA–2014–0309. Their exemptions are effective as of December 29, 2016, and will expire on December 29, 2018. In accordance with 49 U.S.C. 31315, each exemption will be valid for two years from the effective date unless revoked earlier by FMCSA. The exemption will be revoked if the following occurs: (1) The person fails to comply with the terms and conditions of the exemption; (2) the exemption has resulted in a lower level of safety than was maintained prior to being granted; or (3) continuation of the exemption would not be consistent with the goals and objectives of 49 U.S.C. 31136 and 31315. Issued on: February 27, 2017. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2017–04393 Filed 3–6–17; 8:45 am] BILLING CODE 4910–EX–P DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [FMCSA Docket No. FMCSA–2016–0225] Qualification of Drivers; Exemption Applications; Diabetes Mellitus Federal Motor Carrier Safety Administration (FMCSA), DOT ACTION: Notice of final disposition. AGENCY: FMCSA confirms its decision to exempt 52 individuals from its rule prohibiting persons with insulin-treated diabetes mellitus (ITDM) from operating commercial motor vehicles (CMVs) in interstate commerce. The exemptions enable these individuals to operate CMVs in interstate commerce. DATES: The exemptions were effective on December 24, 2016. The exemptions expire on December 24, 2018. FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical SUMMARY: PO 00000 Frm 00109 Fmt 4703 Sfmt 4703 Programs Division, (202) 366–4001, fmcsamedical@dot.gov, FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64– 113, Washington, DC 20590–0001. Office hours are from 8:30 a.m. to 5 p.m. e.t., Monday through Friday, except Federal holidays. SUPPLEMENTARY INFORMATION: I. Electronic Access You may see all the comments online through the Federal Document Management System (FDMS) at: http:// www.regulations.gov. Docket: For access to the docket to read background documents or comments, go to http:// www.regulations.gov and/or Room W12–140 on the ground level of the West Building, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal holidays. Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov, as described in the system of records notice (DOT/ALL–14 FDMS), which can be reviewed at www.dot.gov/privacy. II. Background On November 23, 2016, FMCSA published a notice of receipt of Federal diabetes exemption applications from 52 individuals and requested comments from the public (81 FR 84677). The public comment period closed on December 23, 2016, and no comments were received. FMCSA has evaluated the eligibility of the 52 applicants and determined that granting the exemptions to these individuals would achieve a level of safety equivalent to or greater than the level that would be achieved by complying with the current regulation 49 CFR 391.41(b)(3). Diabetes Mellitus and Driving Experience of the Applicants The Agency established the current requirement for diabetes in 1970 because several risk studies indicated that drivers with diabetes had a higher rate of crash involvement than the general population. The diabetes rule provides that ‘‘A person is physically qualified to drive a commercial motor vehicle if that person has no established medical history or clinical diagnosis of diabetes mellitus currently requiring insulin for control’’ (49 CFR 391.41(b)(3)). E:\FR\FM\07MRN1.SGM 07MRN1 Federal Register / Vol. 82, No. 43 / Tuesday, March 7, 2017 / Notices FMCSA established its diabetes exemption program, based on the Agency’s July 2000 study entitled ‘‘A Report to Congress on the Feasibility of a Program to Qualify Individuals with Insulin-Treated Diabetes Mellitus to Operate in Interstate Commerce as Directed by the Transportation Act for the 21st Century.’’ The report concluded that a safe and practicable protocol to allow some drivers with ITDM to operate CMVs is feasible. The September 3, 2003 (68 FR 52441), Federal Register notice in conjunction with the November 8, 2005 (70 FR 67777), Federal Register notice provides the current protocol for allowing such drivers to operate CMVs in interstate commerce. These 52 applicants have had ITDM over a range of 1 to 24 years. These applicants report no severe hypoglycemic reactions resulting in loss of consciousness or seizure, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning symptoms, in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the past 5 years. In each case, an endocrinologist verified that the driver has demonstrated a willingness to properly monitor and manage his/her diabetes mellitus, received education related to diabetes management, and is on a stable insulin regimen. These drivers report no other disqualifying conditions, including diabetes-related complications. Each meets the vision requirement at 49 CFR 391.41(b)(10). The qualifications and medical condition of each applicant were stated and discussed in detail in the November 23, 2016, Federal Register notice and they will not be repeated in this notice. sradovich on DSK3GMQ082PROD with NOTICES III. Discussion of Comments FMCSA received no comments in this proceeding. IV. Basis for Exemption Determination Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption from the diabetes requirement in 49 CFR 391.41(b)(3) if the exemption is likely to achieve an equivalent or greater level of safety than would be achieved without the exemption. The exemption allows the applicants to operate CMVs in interstate commerce. To evaluate the effect of these exemptions on safety, FMCSA considered medical reports about the applicants’ ITDM and vision, and reviewed the treating endocrinologists’ medical opinion related to the ability of the driver to safely operate a CMV while using insulin. VerDate Sep<11>2014 16:01 Mar 06, 2017 Jkt 241001 Consequently, FMCSA finds that in each case exempting these applicants from the diabetes requirement in 49 CFR 391.41(b)(3) is likely to achieve a level of safety equal to that existing without the exemption. V. Conditions and Requirements The terms and conditions of the exemption will be provided to the applicants in the exemption document and they include the following: (1) That each individual submit a quarterly monitoring checklist completed by the treating endocrinologist as well as an annual checklist with a comprehensive medical evaluation; (2) that each individual reports within 2 business days of occurrence, all episodes of severe hypoglycemia, significant complications, or inability to manage diabetes; also, any involvement in an accident or any other adverse event in a CMV or personal vehicle, whether or not it is related to an episode of hypoglycemia; (3) that each individual provide a copy of the ophthalmologist’s or optometrist’s report to the medical examiner at the time of the annual medical examination; and (4) that each individual provide a copy of the annual medical certification to the employer for retention in the driver’s qualification file, or keep a copy in his/her driver’s qualification file if he/she is selfemployed. The driver must also have a copy of the certification when driving, for presentation to a duly authorized Federal, State, or local enforcement official. VI. Conclusion Based upon its evaluation of the 52 exemption applications, FMCSA exempts the following drivers from the diabetes requirement in 49 CFR 391.41(b)(3), subject to the requirements cited above 49 CFR 391.64(b): Rickey C. Alvis (NC) Vicki L. Bailey (WI) Bennie L. Baker (TX) Darious A. Ballou, III (NC) Salauddin Baset (TX) Emmett G. Bell (DE) Ralph G. Caffee (PA) James L. Calman (WA) Michael J. Carey (NY) David L. Cheshire (MI) Allan S. Clugston (NY) Sean M. Collins (MN) Jimmy D. Curtis (TX) Larry D. Dearth (WI) Keith M. Dickerson (WI) James J. Dorio (PA) Virgil J. Erhardt (IA) Jimmy J. Fanelli (OR) Craig W. Ferris (CT) William L. Garrity (CT) Robin D. Gibson (DC) PO 00000 Frm 00110 Fmt 4703 Sfmt 4703 12891 Richard E. Harger (IN) Steven W. Harry (OR) Jay M. Hill (CO) Paul J. Horne (NY) Eric C. Irwin (IL) John E. Kerby (NE) Adam R. Kleist, Jr. (OR) Jacob A. Knezevich (NM) Joel A. Kroll (SD) Stephen T. Labay (OH) Edwin J. Lundquist (MN) Brian A. McCarthy (GA) Daniel F. Mesiano (WA) Lucjan Metkowski (MI) Stephen C. Mickle (AL) Bryan K. Moreland (CA) Tyler J. Oakland (NE) Yesenia Orozco Marquez (OK) Salvador Pacheco, Jr. (TX) Martin J. Reding (OR) Daniel A. Rivera (FL) Gerald J. Rosauer (WI) Chester G. Selfridge, Jr. (PA) Paul A. Sheehan (PA) Brent L. Stroud (IL) Michael W. Sutton (WA) Carlos Swepson, Sr. (RI) Noah E. Thompson (AL) Thomas P. Verdon (PA) Richard F. Wiltgen (IA) Richard C. Wright (NJ) In accordance with 49 U.S.C. 31136(e) and 31315 each exemption is valid for two years unless revoked earlier by FMCSA. The exemption will be revoked if the following occurs: (1) The person fails to comply with the terms and conditions of the exemption; (2) the exemption has resulted in a lower level of safety than was maintained before it was granted; or (3) continuation of the exemption would not be consistent with the goals and objectives of 49 U.S.C. 31136(e) and 31315. If the exemption is still effective at the end of the 2-year period, the person may apply to FMCSA for a renewal under procedures in effect at that time. Issued on: February 27, 2017. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2017–04384 Filed 3–6–17; 8:45 am] BILLING CODE 4910–EX–P DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket No. FMCSA–2017–0029] Qualification of Drivers; Exemption Applications; Diabetes Mellitus Federal Motor Carrier Safety Administration (FMCSA). ACTION: Notice of applications for exemptions; request for comments. AGENCY: E:\FR\FM\07MRN1.SGM 07MRN1

Agencies

[Federal Register Volume 82, Number 43 (Tuesday, March 7, 2017)]
[Notices]
[Pages 12890-12891]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04384]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[FMCSA Docket No. FMCSA-2016-0225]


Qualification of Drivers; Exemption Applications; Diabetes 
Mellitus

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT

ACTION: Notice of final disposition.

-----------------------------------------------------------------------

SUMMARY: FMCSA confirms its decision to exempt 52 individuals from its 
rule prohibiting persons with insulin-treated diabetes mellitus (ITDM) 
from operating commercial motor vehicles (CMVs) in interstate commerce. 
The exemptions enable these individuals to operate CMVs in interstate 
commerce.

DATES: The exemptions were effective on December 24, 2016. The 
exemptions expire on December 24, 2018.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, 
Medical Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, 
Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113, 
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m. 
e.t., Monday through Friday, except Federal holidays.

SUPPLEMENTARY INFORMATION: 

I. Electronic Access

    You may see all the comments online through the Federal Document 
Management System (FDMS) at: http://www.regulations.gov.
    Docket: For access to the docket to read background documents or 
comments, go to http://www.regulations.gov and/or Room W12-140 on the 
ground level of the West Building, 1200 New Jersey Avenue SE., 
Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, 
except Federal holidays.
    Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits 
comments from the public to better inform its rulemaking process. DOT 
posts these comments, without edit, including any personal information 
the commenter provides, to www.regulations.gov, as described in the 
system of records notice (DOT/ALL-14 FDMS), which can be reviewed at 
www.dot.gov/privacy.

II. Background

    On November 23, 2016, FMCSA published a notice of receipt of 
Federal diabetes exemption applications from 52 individuals and 
requested comments from the public (81 FR 84677). The public comment 
period closed on December 23, 2016, and no comments were received.
    FMCSA has evaluated the eligibility of the 52 applicants and 
determined that granting the exemptions to these individuals would 
achieve a level of safety equivalent to or greater than the level that 
would be achieved by complying with the current regulation 49 CFR 
391.41(b)(3).

Diabetes Mellitus and Driving Experience of the Applicants

    The Agency established the current requirement for diabetes in 1970 
because several risk studies indicated that drivers with diabetes had a 
higher rate of crash involvement than the general population. The 
diabetes rule provides that ``A person is physically qualified to drive 
a commercial motor vehicle if that person has no established medical 
history or clinical diagnosis of diabetes mellitus currently requiring 
insulin for control'' (49 CFR 391.41(b)(3)).

[[Page 12891]]

    FMCSA established its diabetes exemption program, based on the 
Agency's July 2000 study entitled ``A Report to Congress on the 
Feasibility of a Program to Qualify Individuals with Insulin-Treated 
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the 
Transportation Act for the 21st Century.'' The report concluded that a 
safe and practicable protocol to allow some drivers with ITDM to 
operate CMVs is feasible. The September 3, 2003 (68 FR 52441), Federal 
Register notice in conjunction with the November 8, 2005 (70 FR 67777), 
Federal Register notice provides the current protocol for allowing such 
drivers to operate CMVs in interstate commerce.
    These 52 applicants have had ITDM over a range of 1 to 24 years. 
These applicants report no severe hypoglycemic reactions resulting in 
loss of consciousness or seizure, requiring the assistance of another 
person, or resulting in impaired cognitive function that occurred 
without warning symptoms, in the past 12 months and no recurrent (2 or 
more) severe hypoglycemic episodes in the past 5 years. In each case, 
an endocrinologist verified that the driver has demonstrated a 
willingness to properly monitor and manage his/her diabetes mellitus, 
received education related to diabetes management, and is on a stable 
insulin regimen. These drivers report no other disqualifying 
conditions, including diabetes-related complications. Each meets the 
vision requirement at 49 CFR 391.41(b)(10).
    The qualifications and medical condition of each applicant were 
stated and discussed in detail in the November 23, 2016, Federal 
Register notice and they will not be repeated in this notice.

III. Discussion of Comments

    FMCSA received no comments in this proceeding.

IV. Basis for Exemption Determination

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption 
from the diabetes requirement in 49 CFR 391.41(b)(3) if the exemption 
is likely to achieve an equivalent or greater level of safety than 
would be achieved without the exemption. The exemption allows the 
applicants to operate CMVs in interstate commerce.
    To evaluate the effect of these exemptions on safety, FMCSA 
considered medical reports about the applicants' ITDM and vision, and 
reviewed the treating endocrinologists' medical opinion related to the 
ability of the driver to safely operate a CMV while using insulin.
    Consequently, FMCSA finds that in each case exempting these 
applicants from the diabetes requirement in 49 CFR 391.41(b)(3) is 
likely to achieve a level of safety equal to that existing without the 
exemption.

V. Conditions and Requirements

    The terms and conditions of the exemption will be provided to the 
applicants in the exemption document and they include the following: 
(1) That each individual submit a quarterly monitoring checklist 
completed by the treating endocrinologist as well as an annual 
checklist with a comprehensive medical evaluation; (2) that each 
individual reports within 2 business days of occurrence, all episodes 
of severe hypoglycemia, significant complications, or inability to 
manage diabetes; also, any involvement in an accident or any other 
adverse event in a CMV or personal vehicle, whether or not it is 
related to an episode of hypoglycemia; (3) that each individual provide 
a copy of the ophthalmologist's or optometrist's report to the medical 
examiner at the time of the annual medical examination; and (4) that 
each individual provide a copy of the annual medical certification to 
the employer for retention in the driver's qualification file, or keep 
a copy in his/her driver's qualification file if he/she is self-
employed. The driver must also have a copy of the certification when 
driving, for presentation to a duly authorized Federal, State, or local 
enforcement official.

VI. Conclusion

    Based upon its evaluation of the 52 exemption applications, FMCSA 
exempts the following drivers from the diabetes requirement in 49 CFR 
391.41(b)(3), subject to the requirements cited above 49 CFR 391.64(b):

Rickey C. Alvis (NC)
Vicki L. Bailey (WI)
Bennie L. Baker (TX)
Darious A. Ballou, III (NC)
Salauddin Baset (TX)
Emmett G. Bell (DE)
Ralph G. Caffee (PA)
James L. Calman (WA)
Michael J. Carey (NY)
David L. Cheshire (MI)
Allan S. Clugston (NY)
Sean M. Collins (MN)
Jimmy D. Curtis (TX)
Larry D. Dearth (WI)
Keith M. Dickerson (WI)
James J. Dorio (PA)
Virgil J. Erhardt (IA)
Jimmy J. Fanelli (OR)
Craig W. Ferris (CT)
William L. Garrity (CT)
Robin D. Gibson (DC)
Richard E. Harger (IN)
Steven W. Harry (OR)
Jay M. Hill (CO)
Paul J. Horne (NY)
Eric C. Irwin (IL)
John E. Kerby (NE)
Adam R. Kleist, Jr. (OR)
Jacob A. Knezevich (NM)
Joel A. Kroll (SD)
Stephen T. Labay (OH)
Edwin J. Lundquist (MN)
Brian A. McCarthy (GA)
Daniel F. Mesiano (WA)
Lucjan Metkowski (MI)
Stephen C. Mickle (AL)
Bryan K. Moreland (CA)
Tyler J. Oakland (NE)
Yesenia Orozco Marquez (OK)
Salvador Pacheco, Jr. (TX)
Martin J. Reding (OR)
Daniel A. Rivera (FL)
Gerald J. Rosauer (WI)
Chester G. Selfridge, Jr. (PA)
Paul A. Sheehan (PA)
Brent L. Stroud (IL)
Michael W. Sutton (WA)
Carlos Swepson, Sr. (RI)
Noah E. Thompson (AL)
Thomas P. Verdon (PA)
Richard F. Wiltgen (IA)
Richard C. Wright (NJ)

    In accordance with 49 U.S.C. 31136(e) and 31315 each exemption is 
valid for two years unless revoked earlier by FMCSA. The exemption will 
be revoked if the following occurs: (1) The person fails to comply with 
the terms and conditions of the exemption; (2) the exemption has 
resulted in a lower level of safety than was maintained before it was 
granted; or (3) continuation of the exemption would not be consistent 
with the goals and objectives of 49 U.S.C. 31136(e) and 31315. If the 
exemption is still effective at the end of the 2-year period, the 
person may apply to FMCSA for a renewal under procedures in effect at 
that time.

    Issued on: February 27, 2017.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2017-04384 Filed 3-6-17; 8:45 am]
 BILLING CODE 4910-EX-P